Loading clinical trials...
Loading clinical trials...
An Open-Label, Repeat-Dose Study to Evaluate the Pharmacokinetics of Orally Administered CORT125134 Using the Current Capsule Formulation in Healthy Subjects
Conditions
Interventions
CORT125134 150 mg
CORT125134 250 mg
+1 more
Locations
1
United States
Quotient Sciences, Miami, Inc.
Miami, Florida, United States
Start Date
May 18, 2017
Primary Completion Date
November 15, 2017
Completion Date
November 15, 2017
Last Updated
October 23, 2023
NCT07310264
NCT06290258
NCT00090662
NCT06716502
NCT07483606
NCT07310901
Lead Sponsor
Corcept Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions